DMK PHARMACEUTICALS Corp (DMKPQ) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
11682 EL CAMINO REAL SAN DIEGO, CA 92130 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 640 | 3,100 | 1,081 | 2,420 | 8,876 | 17,768 | |||
| Cash and cash equivalents | 640 | 3,100 | 1,081 | 2,420 | 8,876 | 17,768 | |||
| Restricted cash and investments | 30 | 30 | 30 | 30 | 30 | 30 | |||
| Receivables | 19 | 21 | 31 | 248 | 956 | 3,085 | |||
| Inventory, net of allowances, customer advances and progress billings | 664 | 664 | 1,239 | 1,092 | 440 | 32 | |||
| Inventory | 664 | 664 | 1,239 | 1,092 | 440 | 32 | |||
| Prepaid expense | 207 | 415 | 402 | ||||||
| Disposal group, including discontinued operation | 1,439 | 2,981 | 3,953 | 4,188 | 4,223 | 4,277 | |||
| Other current assets | 48 | 6 | 19 | ||||||
| Other undisclosed current assets | 403 | 329 | 2,518 | 2,110 | 796 | 2,599 | |||
| Total current assets: | 3,451 | 7,547 | 9,272 | 10,088 | 15,321 | 27,790 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 146 | 232 | 318 | 402 | 486 | 569 | |||
| Property, plant and equipment | 1,143 | 1,245 | 1,289 | 1,595 | 1,836 | 2,138 | |||
| Other noncurrent assets | 10 | 52 | 52 | 52 | 52 | 52 | |||
| Total noncurrent assets: | 1,298 | 1,529 | 1,659 | 2,049 | 2,374 | 2,759 | |||
| TOTAL ASSETS: | 4,749 | 9,076 | 10,931 | 12,137 | 17,694 | 30,549 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 13,567 | 11,611 | 9,448 | 6,639 | 7,192 | 7,743 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | ✕ | 530 | 353 | ||
| Accounts payable | 11,366 | 9,781 | 7,937 | 5,298 | 4,517 | 4,891 | |||
| Accrued liabilities | 2,201 | 1,830 | 1,510 | 1,342 | 2,145 | 2,499 | |||
| Deferred revenue | 175 | 28 | 28 | 28 | 100 | 100 | |||
| Disposal group, including discontinued operation | 933 | 930 | 1,272 | 1,430 | 1,468 | 1,534 | |||
| Other undisclosed current liabilities | 332 | 381 | 648 | 777 | 964 | 4,206 | |||
| Total current liabilities: | 15,007 | 12,949 | 11,396 | 8,874 | 9,724 | 13,583 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation: | 63 | 157 | 250 | ||||||
| Liabilities, other than long-term debt | 1,237 | 5,652 | 186 | 197 | 771 | 815 | |||
| Deferred revenue | 164 | 171 | 178 | 185 | 700 | 725 | |||
| Operating lease, liability | 63 | 157 | 250 | ||||||
| Derivative instruments and hedges, liabilities | 1,073 | 5,481 | 7 | 12 | 71 | 90 | |||
| Total noncurrent liabilities: | 1,237 | 5,652 | 186 | 260 | 928 | 1,066 | |||
| Total liabilities: | 16,244 | 18,600 | 11,582 | 9,135 | 10,652 | 14,649 | |||
| Temporary equity, carrying amount | 330 | 157 | 157 | 157 | |||||
| Equity | |||||||||
| Equity, attributable to parent | (11,825) | (9,682) | (808) | 2,845 | 7,042 | 15,900 | |||
| Common stock | 16 | 15 | 15 | 15 | 15 | 15 | |||
| Treasury stock, value | (5) | (5) | (5) | (5) | (5) | (5) | |||
| Additional paid in capital | 310,245 | 303,816 | 303,746 | 304,072 | 303,870 | 304,331 | |||
| Accumulated deficit | (322,081) | (313,507) | (304,564) | (301,237) | (296,838) | (288,440) | |||
| Total equity: | (11,825) | (9,682) | (808) | 2,845 | 7,042 | 15,900 | |||
| TOTAL LIABILITIES AND EQUITY: | 4,749 | 9,076 | 10,931 | 12,137 | 17,694 | 30,549 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 7 | 1,453 | 2,151 | 1,506 | 40 | 1,155 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (361) | (1,788) | (2,482) | (1,648) | (689) | (1,464) | ||
| Gross profit: | (354) | (335) | (331) | (142) | (649) | (309) | ||
| Operating expenses | (10,950) | (6,093) | (4,011) | (4,486) | (7,527) | (7,604) | ||
| Operating loss: | (11,304) | (6,428) | (4,342) | (4,628) | (8,176) | (7,913) | ||
| Nonoperating income (expense) | 4,301 | (2,587) | 941 | 357 | (160) | (2,276) | ||
| Other nonoperating income (expense) | 463 | (113) | 298 | (258) | (440) | |||
| Interest and debt expense | (46) | 63 | (1,850) | |||||
| Loss from continuing operations before income taxes: | (7,050) | (9,015) | (3,401) | (4,271) | (8,273) | (12,040) | ||
| Other undisclosed loss from continuing operations | (2) | |||||||
| Loss from continuing operations: | (7,050) | (9,015) | (3,403) | (4,271) | (8,273) | (12,040) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (4,399) | (8,335) | (12,205) | |
| Income (loss) from discontinued operations | 72 | 75 | (128) | (62) | (165) | |||
| Net loss: | (7,050) | (8,943) | (3,328) | (4,399) | (8,335) | (12,205) | ||
| Other undisclosed net income (loss) attributable to parent | (1,524) | (63) | 1,850 | |||||
| Net loss attributable to parent: | (8,574) | (8,943) | (3,328) | (4,399) | (8,397) | (10,355) | ||
| Preferred stock dividends and other adjustments | (173) | |||||||
| Net loss available to common stockholders, diluted: | (8,747) | (8,943) | (3,328) | (4,399) | (8,397) | (10,355) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (7,050) | (8,943) | (3,328) | (4,399) | (8,335) | (12,205) | ||
| Comprehensive loss, net of tax, attributable to parent: | (7,050) | (8,943) | (3,328) | (4,399) | (8,335) | (12,205) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.